PATENT CLAIM ANALYSIS

Application Number: 16011068
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "062000"]

Abstract:
The present invention provides dosing regimens for administering pharmacological chaperones to a subject in need thereof. The dosing regimens can be used to treat disorders caused by improper protein misfolding, such as lysosomal storage disorders.

Claim (Index 35):
The method of  claim 31 , wherein the 1-deoxygalactonojirimycin or salt thereof enhances \u03b1-galactosidase A activity.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15213920', '12597238', '14054369', '12855468', '14731603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8131624230966518
- 35 USC 102 Novelty (BERT): 0.6391092446769376
- Combined Prediction Score: 0.7957571052546804
- Mean Citation Score: 519.3931279999998
- Max Citation Score: 654.27124
- Similarity Product: 533.8067026852417

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test